Prompted by previous observations that polymannose oligosaccharides are released from newly synthesized glycoproteins [Anumula and Spiro (1983) J. Biol. Chem. 258, 15274-15282], we examined rat liver endoplasmic reticulum (ER) for the presence of endoglycosidases that could be involved in an event presumed to be a function of the protein quality control machinery. Our investigations indicated that a peptide : N-glycanase (PNGase) is present in ER membranes that has the capacity to release from radiolabelled glycopeptides glucosylated as well as nonglucosylated polymannose oligosaccharides terminating at their reducing end in a di-N-acetylchitobiose sequence (OS-GlcNAc # ). This enzyme, which was found to be luminal in orientation, was most active in the pH range 5n5-7n0 and although it had no exogenous bivalent-cation requirements it was inhibited by
INTRODUCTION
In recent years, studies from our laboratory [1] [2] [3] , as well as those of other investigators [4] [5] [6] , have shown that there is a release of free polymannose oligosaccharides concurrently or shortly after N-glycosylation takes place in the endoplasmic reticulum (ER). These components have been shown to consist of two families, which differ from each other in having either a di-N-acetylchiotobiose sequence (OS-GlcNAc # ) or a single Nacetylglucosamine residue (OS-GlcNAc " ) at their reducing ends [1, 3] . Although neither group of oligosaccharides is secreted by the cell [7] , components belonging to the latter category have attracted particular attention since studies with permeabilized HepG2 cells indicated that after their generation from newly synthesized glycoproteins [2] , they rapidly appear in the cytosol [3] where an α-mannosidase closely related to ER mannosidase II [8] processes them to the Man & GlcNAc " stage [8, 9] ; subsequently this oligosaccharide becomes internalized into a compartment that is believed to be the lysosomes, where enzymes are located that can perform its further degradation [9] .
On the basis of these observations it has been postulated [3] that the release of these oligosaccharides might be a function of the ER-situated quality-control machinery, which is believed to degrade misfolded or improperly assembled proteins [10] . An ER-cytosolic translocation of released oligosaccharides would prevent their accumulation in the channels of the secretory system, where they would have the potential of interfering with the lectin-like chaperone interactions that have been shown to involve N-linked oligosaccharides [11, 12] 
or to compete
Abbreviations used : ER, endoplasmic reticulum ; OS-GlcNAc 1 and OS-GlcNAc 2 , polymannose oligosaccharides terminating at their reducing end with an N-acetylglucosamine or a di-N-acetylchitobiose sequence respectively ; PNGase, peptide : N-glycosidase ; KIF, kifunensine ; DIM, 1,4-dideoxy-1,4-imino-D-mannitol ; CST, castanospermine ; DMJ, 1-deoxymannojirimycin ; endo H, endo-β-N-acetylglucosaminidase H.
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EDTA. Detailed studies with Man * GlcNAc # -peptides demonstrated that in addition to the free oligosaccharide (Man * GlcNAc # ) an additional neutral product characterized as Man * GlcNAc # linked to an as yet unidentified aglycone was released in a manner that suggests its role as an intermediate. Our observation that ER, in contrast with cytosol, had no endo-β-Nacetylglucosaminidase activity would indicate that oligosaccharides terminating in a single GlcNAc residue (OSGlcNAc " ), which have been noted to appear in the extravesicular compartment shortly after N-glycosylation [Moore and Spiro (1994) J. Biol. Chem. 269, 12715-12721] are released from the protein as OS-GlcNAc # and undergo an ER-to-cytosol translocation in that form before undergoing cleavage of their chitobiose core.
with intravesicular processing enzymes or saccharide-specific receptors [13] .
Although previous studies have indicated that OS-GlcNAc # components can be generated by the hydrolytic capacity of oligosaccharyltransferase [2] , the possibility that the release of oligosaccharides in the ER can be brought about by the action of endoglycosidases, such as peptide : N-glycosidase (PNGase) or endo-β-N-acetylglucosaminidase, which are known to be widely distributed in Nature [14, 15] , has not been explored. Therefore we have in the present study undertaken a search for such hydrolytic enzymes in rat liver ER. Our observations indicate that there is a PNGase in this subcellular compartment that in itro can effectively release polymannose oligosaccharides of the OS-GlcNAc # type from exogenous glycopeptides. Furthermore our finding that, in contrast with the cytosol, the ER does not have detectable endo-β-N-acetylglucosaminidase activity supports the concept that OS-GlcNAc # components are translocated into the cytosol after their formation in the ER and are then converted into OS-GlcNAc " saccharide species.
EXPERIMENTAL Preparation of rat liver ER
Rough ER was prepared from the livers of fasted male rats (175-200 g, CD strain ; Taconic) by the procedure of DePierre and Dallner [16] , as previously employed [8, 17, 18] . The purity of the ER prepared in this manner has previously been evaluated by marker enzyme assays [17] , which indicated on the basis of UDP-Gal : N-acetylglucosamine galactosyltransferase determinations that there is less than 2 % Golgi contamination.
Preparation of radiolabelled glycopeptides

Mixed
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C-labelled polymannose-GlcNAc 2 glycopeptides
For the preparation of glycopeptides, calf thyroid slices were incubated with [U-"%C]glucose (325 mCi\mmol ; DuPont-New England Nuclear) for 3 h at 37 mC as previously described [19] . After delipidation of the postnuclear pellet by successive chloroform\methanol\water (3 : 2 : 1, by vol.) and chloroform\ methanol\water (10 : 10 : 3, by vol.) extractions, it was submitted to Pronase (Calbiochem) digestion to prepare a mixture of complex and polymannose N-linked glycopeptides as previously reported [20] . To obtain the polymannose-containing peptides, the total glycopeptide fraction (500 000 d.p.m.) was applied to a concanavalin A-Sepharose column (0n7 cmi4 cm) (Pharmacia Biotech) in a manner previously described [21] , from which they were eluted, after an extensive buffer wash, with 500 mM methyl-α--mannoside. The glycopeptides, which contained N-linked oligosaccharides ranging in size from Man & GlcNAc
, were then desalted and separated from the methylglycoside by filtration on Bio-Gel P-2 column (1n5 cmi32 cm) equilibrated with a 0n1 M pyridine acetate (pH 5n0) buffer which was subsequently removed by freezedrying.
C-labelled Man 6 GlcNAc 2 -glycopeptides
For the preparation of "%C-labelled Man * GlcNAc # -peptides, the thyroid slices were incubated for 3 h with ["%C]glucose in the presence of 0n1 mM kifunensine (KIF) (Toronto Research Chemicals) and 2 mM 1,4-dideoxy-1,4-imino--mannitol (DIM) (Oxford GlycoSystems) to inhibit ER and Golgi mannosidases I as well as ER mannosidase II [8, 18] In order to radiolabel the GlcNAc residues selectively in the polymannose glycopeptides, BW5147.3 mouse lymphoma cells (2i10)), obtained from ATCC (Rockville, MD, U.S.A.) and grown as previously described [18] , were pulsed in suspension for 45 min with 500 µCi of [6-$H]glucosamine (33 mCi\µmol ; DuPont-New England Nuclear) in 2 ml of glucose-free Dulbecco's modified Eagle's medium containing 10 mM sodium pyruvate and 0n1 mM KIF as well as 2 mM DIM. This was followed by a 1 h chase in the presence of 2 mM mannose as well as 4n5 mg\ml glucose. A 15-min incubation at 37 mC with the mannosidase inhibitors preceded the addition of the radioactive substrate, and moreover these agents were present during the chase. After the incubation the cells were separated from the medium, delipidated and digested with Pronase as described for the thyroid glycoproteins.
Glc 3 Man 9 GlcNAc 2 glycopeptides
The mouse BW5147.3 lymphoma cells were also employed to prepare glycopeptides in which Glc $ Man * GlcNAc # oligosaccharides predominated. For this purpose incubations (20 min pulse followed by 2 h chase) were performed with 300 µCi of [2-$H]mannose (28 mCi\mol ; DuPont-New England Nuclear) in the presence of 0n2 mM 6-O-butanoyl castanospermine (CST) (a gift from Dr M. Kang, Merrell Dow Research Institute, Cincinnati, OH, U.S.A.) and 0n2 mM KIF. Parallel incubations were performed in the absence of the glucosidase inhibitor to yield glycopeptides containing primarily N-linked Man * GlcNAc # oligosaccharides. Purification of these glycopeptides was achieved by concanavalin A chromatography as described above.
Radiolabelled peptide-linked Glc $ Man * GlcNAc # was also prepared through the action of rat liver oligosaccharyltransferase. In this approach "%C-labelled oligosaccharide-lipid (200 000 d.p.m.) prepared in thyroid slices as previously described [22] was incubated with the liver ER membranes (1n0 mg of protein) for 30 min at 27 mC in 100 µl of 50 µM Tris\acetate, pH 7n4, buffer containing 0n2 % Triton X-100, 2 mM manganese acetate, 2 mM 2-mercaptoethanol, 5 µM KIF, 2 mM DIM and 2 mM CST. The Glc $ Man * GlcNAc # -peptides were obtained after Pronase digestion of the delipidated protein pellet as described above ; the Glc $ Man * GlcNAc # nature of the oligosaccharide unit was confirmed by TLC after digestion with endo-β-Nacetylglucosaminidase H (endo H).
All polymannose glycopeptide substrates were digested with endo H to determine their oligosaccharide composition and the amount of radiolabel in each component.
Assay of PNGase
In the standard assay a specified amount of rat liver ER (25-300 µg of protein) was incubated with the "%C-labelled
in the oligosaccharide] for various times (4-40 h) at 37 mC in 50 µl of 0n1 M NaMes buffer, pH 6n5, containing 5 µM KIF, 2 mM 1-deoxymannojirimycin (DMJ) (Genzyme) and 0n2 % (v\v) Triton X-100. When glycopeptides containing glucosylated polymannose oligosaccharides were assayed, CST (2 mM) was also included in the incubations ; all assays were preceded by a 40 min incubation at 2 mC without substrate to maximize the effect of the glycosidase inhibitors. The incubations were terminated by heating at 100 mC for 3 min after the addition of 0n5 ml of water. The samples were then passed through columns containing 1 ml of Dowex 1-X2, 200-400 mesh (acetate form), overlaid by 1 ml of Dowex 50-X2, 200-400 mesh (H + form) to yield in the water wash the released neutral oligosaccharides, which were then subjected to TLC on silica-gel-coated plates in solvent system A [propan-1-ol\acetic acid\water (3 : 3 : 2, by vol.)]. The saccharide components were detected by fluorography and quantified by scintillation counting after elution from the chromatograms.
Latency examination of PNGase in the ER
For these studies, the ER vesicles obtained from the sucrose gradient were washed twice by centrifugation (100 000 g for 60 min) with 0n25 M sucrose in 5 mM Tris\acetate, pH 7n0. They were then suspended in this buffer and kept at 4 mC for 30 min with or without 0n2 % (v\v) Triton X-100 in the presence of 5 µM KIF and 2 mM DMJ before the addition of the "%C-labelled Man * GlcNAc # -glycopeptide substrate (25 000 d.p.m.). The assay was performed in a 100 µl volume for 4 h at 37 mC ; after its termination by heating at 100 mC for 3 min, the samples were loaded on Bio-Gel P-2 columns (1n5 cmi32 cm) equilibrated with 0n1 M pyridine acetate, pH 5n0, to remove the sucrose. The radioactive fractions were pooled, freeze-dried to remove the buffer and then passed through Dowex 50 (H + form)\Dowex 1 (acetate form) columns to obtain the released oligosaccharides, which were then subjected to TLC, fluorography and scintillation counting. As a positive control mannose-6-phosphatase activity was determined as previously described [8] . Peptide : N-glycosidase in endoplasmic reticulum of liver
Assay of endo β-N-acetylglucosaminidase activity
Determination of the activity of this enzyme in rat liver ER and dialysed cytosol was performed with 4000 d.p.m. of "%C-labelled Glc $ Man * GlcNAc # , prepared by mild acid hydrolysis of metabolically labelled thyroid oligosaccharide-lipids [1] , in 50 µl of 0n1 M NaMes buffer, pH 6n5, containing 2 mM CST, 5 µM KIF and 2 mM DMJ as well as 0n2 % (v\v) Triton X-100 for 90 min at 37 mC. After desalting of the samples by passage through Dowex 50 (H + form)\Dowex 1 (acetate form) columns, the products of the incubations were identified by TLC.
Structural and analytical procedures
Reduction of oligosaccharides was performed with NaBH % as previously described [17] and the desalted oligosaccharide products, after removal of the borate with methanol, were examined by TLC. Digestions with recombinant Streptomyces plicatus endo H (2 m-units ; Genzyme) were performed as previously described [20] and the desalted samples were examined by TLC. Protein was determined by the procedure of Peterson [23] , with BSA as a standard.
TLC
Oligosaccharides were resolved on plastic sheets precoated with silica gel 60 (0n2 mm thickness ; Merck) in solvent system A (propan-1-ol\acetic acid\water ; 3 : 3 : 2, by vol.), whereas monosaccharides were separated on plastic sheets precoated with cellulose (0n1 mm thickness ; Merck) in pyridine\ethyl acetate\water\acetic acid (5 : 5 : 3 : 1, by vol.) (solvent system B). The chromatography in both systems was performed with a wick of Whatman 3 MM paper clamped to the top of the thin-layer plates ; the radioactive components were located by fluorography and quantified by scintillation counting after elution with water as previously described [7] . For preparative purposes, oligosaccharide eluates were extracted with peroxide-free diethyl ether to remove scintillants and passed through small columns of Dowex 50 (H + form)\Dowex 1 (acetate form).
Measurements of radioactivity
Liquid-scintillation counting was performed in Ultrafluor with a Beckman LS 7500 instrument. Radioactive components on thin-layer plates were detected with X-Omatic AR film (Eastman Kodak) after spraying with a scintillation mixture containing 2-methylnaphthalene [24] .
RESULTS
Release of free oligosaccharides from polymannose-glycopeptides by rat liver ER
Incubation of ER membranes with a mixture of radiolabelled polymannose-containing peptides resulted in the release of a series of oligosaccharides that migrated on TLC as OS-GlcNAc # components (Man * GlcNAc # to Man & GlcNAc # ) and accordingly were converted into their respective OS-GlcNAc " forms on subsequent digestion with endo H (Figure, 1, left panel) . These observations suggested that rat liver ER manifests PNGase activity and that this enzyme acts on the entire complement of Nlinked polymannose oligosaccharides. Indeed on the basis of the oligosaccharide species released by direct treatment of this glycopeptide mixture with endo H, it could be calculated that the ER enzyme had released approx. 50 % (range 45-58 %) of the Man & -* GlcNAc # components. Moreover, we observed that the enzyme effectively released Glc $ Man * GlcNAc # from peptides containing the glucosylated oligosaccharide, irrespective of whether they were prepared in thyroid slices or by oligosaccharyltransferase action in a cell-free system. In contrast, dolichylpyrophosphate-linked Glc $ Man * GlcNAc # was not cleaved by the enzyme ; the absence of bivalent cations in our PNGase assay prevented this substrate from being transferred to
Figure 1 Thin-layer chromatographic examination of oligosaccharides released by rat liver ER from radiolabelled polymannose glycopeptides and evaluation of the effect of endo H treatment on these components
Figure 3 Effect of pH on PNGase activity from rat liver ER
ER membranes (100 µg of protein) were incubated at the indicated pH values with 14 C-labelled Man 9 GlcNAc 2 -glycopeptide (9600 d.p.m.) for 20 h at 37 mC as described in the Experimental section. The released Man 9 GlcNAc 2 was quantified after TLC. The buffers (0n1 M) employed in this study were : pH 4n5-5n5, acetate ; pH 6n0-7n0, Mes ; and pH 7n5-8n5, phosphate.
endogenous protein by ER oligosaccharyltransferase, which is known to function only in the presence of these cofactors [22] .
For the standard assay we chose to employ as substrate glycopeptides containing N-linked Man * GlcNAc # from which the ER released an oligosaccharide that was converted into Man * GlcNAc " after treatment with endo H (Figure 1, right  panel) . A more slowly migrating component, the intensity of which varied with the length of incubation, the amount of enzyme and the length of enzyme storage at k20 mC, was also observed on TLC ; the nature of this product will be evaluated in a subsequent section of this paper.
Properties of PNGase in rat liver ER
Assays with the Man * GlcNAc # -peptides (Figure 2 ) revealed that the amount of free oligosaccharide released by the ER enzyme increased with time over a 40 h period and demonstrated a linear response to ER protein (25-150 µg) as well as glycopeptide substrate (5000-20 000 d.p.m.). The pH optimum of the enzyme was evident over the pH range 5n5-7n0 (Figure 3) .
Although the enzyme assay was performed in the absence of exogenous bivalent cations, the addition of EDTA almost completely inhibited activity with 23 % and 13 % of control values being observed at 5 and 10 mM respectively of this chelator. The addition of 10 mM concentrations of a variety of metal ions, including Mn# + , Mg# + , Ca# + , Co# + and Zn# + , to incubations containing 5 mM EDTA failed to reverse this inhibition. Furthermore, additions of these ions (2 mM) in the absence of EDTA did not enhance activity and indeed Co# + , Zn# + and Mn# + were inhibitory, decreasing enzyme activity to 28 %, 51% and 33 % of control incubations.
Latency of PNGase in ER
Determination of the enzyme activity of intact ER vesicles with and without 0n2 % Triton X-100, as described in the Experimental section, indicated that the catalytic site of the PNGase was luminal in orientation, as cleavage of the glycopeptide after a 4 h incubation in the absence of the permeabilizing detergent was only 11 % of that noted in its presence (50 d.p.m. compared with 463 d.p.m.). ER mannose-6-phosphatase activity, which served 14 C-labelled Man 9 GlcNAc 2 -glycopeptide (9600 d.p.m.) at 37 mC as described in the Experimental section. The released, desalted neutral components were chromatographed on silica-gel-coated plates in solvent system A for 24 h and detection was achieved by fluorography. In addition to the Man 9 GlcNAc 2 (M 9 GN 2 ), another more slowly migrating radiolabelled component was observed, which has been designated Man 9 GlcNAc 2 -X (M 9 GN 2 -X) on the basis of the subsequent characterization studies. A small amount of Man 8 GlcNAc 2 , migrating ahead of Man 9 GlcNAc 2 , can be observed at the longer incubation times.
as a control, reflected a similar response to that of PNGase to the detergent as previously reported [8] .
Characterization of the more slowly migrating component ( OSGlcNAc 2 -X ) released by rat liver ER enzyme
TLC examination of the products of Man * GlcNAc # -peptide cleavage by ER enzyme revealed, in addition to the free oligosaccharide, the presence of another radiolabelled component that migrated at only 0n63 times the rate of Man * GlcNAc # . Although the intensity of the slower component, which we termed Man * GlcNAc # -X, varied between ER preparations, depending on the length of frozen storage of the membranes, its appearance was in general related to the length of incubation (Figure 4 , left panel) and amount of enzyme (Figure 4 , right panel) in such a manner as to suggest that it might be an intermediate in the release of the free oligosaccharide. Such an interrelationship was also supported by a parallel response of the two components to EDTA, pH and Triton X-100 (results not shown). The possibility of a product-precursor relationship was furthermore indicated by the conversion of the purified slower component into Man * GlcNAc # on digestions with ER membranes ( Figure 5 ).
The observation that digestion of the slow oligosaccharide with endo H resulted in the formation of Man * GlcNAc " in a manner comparable with such treatment of Man * GlcNAc # ( Figure 6 , left panel) suggested that Man * GlcNAc # -X differed from Man * GlcNAc # in having its internal GlcNAc residue either O-substituted or in glycosidic linkage to an additional constituent, which in either case should be excised together with the terminal GlcNAc by endo H. The latter situation seemed to exist because the chromatographic migration of Man * GlcNAc # -X was not altered by reduction with NaBH % , in contrast with that of the Man * GlcNAc # oligosaccharide itself, which demonstrated the expected decrease in mobility (Figure 7) .
In an attempt to characterize the nature of the aglycone, we chromatographically surveyed the cleavage products from endo H action on [$H]GlcNAc-labelled Man * GlcNAc # -X alongside those obtained from Man * GlcNAc # radiolabelled in the same manner. Although GlcNAc was released from the latter component ( Figure 6 , right panel), which was consistent with its increase in chromatographic mobility ( Figure 6 , left panel), no released product could be detected from endo H action on Man * GlcNAc # -X ( Figure 6 , right panel) despite clear evidence that cleavage by the enzyme had taken place with its conversion into the Man * GlcNAc " oligosaccharide ( Figure 6 , left panel). Indeed the expected released radiolabelled GlcNAc-X could not be detected even when the solvent front was not permitted to move off the chromatographic plate. Although Man * GlcNAc # -X is believed to be a neutral component because it is not bound to either the Dowex 50 or Dowex 1 employed in the PNGase assay, the possibility that the excised N-acetylglucosaminide (GlcNAc-X) might nevertheless bear a charge was made unlikely by our observation that when the endo H digest was passed through these exchangers no radioactivity could be recovered by their elution with 1n5 M NH % OH (Dowex 50) or 3 M formic acid (Dowex 1).
Incubation of ER enzyme with radiolabelled Glc $ Man * GlcNAc # -glycopeptides indicated that N-linked oligosaccharides in the glucosylated form are released as OS-GlcNAc # and OS-GlcNAc # -X in a manner comparable with that of the nonglucosylated species (Figure 8) . Moreover, when the slower TLC was performed on a silica gel-coated plate for 24 h in solvent system A on chromatographically purified Man 9 GlcNAc 2 (M 9 GN 2 ) and Man 9 GlcNAc 2 -X (M 9 GN 2 -X) before (Control) and after (NaBH 4 ) reduction. The components were revealed by fluorography.
peptides was treated with endo H, it was also converted into the Glc $ Man * GlcNAc " oligosaccharide (results not shown).
Evaluation of ER endo-β-N-acetylglucosaminidase activity
Because our laboratory has previously reported that OS-GlcNAc " as well OS-GlcNAc # components are released shortly after N- Figure 4 . Each substrate yielded, in addition to the di-N-acetylchitobiose-terminating oligosaccharide (G 3 M 9 GN 2 and M 9 GN 2 respectively), other more slowly migrating components, which have been designated G 3 M 9 GN 2 -X and M 9 GN 2 -X.
Figure 9 Evaluation of endo-β-N-acetylglucosaminidase activity in rat liver ER and cytosol
